Posted on April 27, 2009 by cartier@bio
A two-time cancer survivor and a perennial Republican swing voter, Senator Arlen Specter (R-PA), urged the creation of the Cures Acceleration Network, a new agency to provide grants to help biotech companies develop new treatments, reports Reuters and The Boston Globe:
I believe that we can live not only longer lives, but healthier lives, by harnessing [...]
Filed under: Congress, Finding Cures, In the News, Uncategorized | Tagged: Cures Acceleration Network, Specter | Leave a Comment »
Posted on September 25, 2008 by cartier@bio
The Parkinson’s Action Network sent this to us for our blog:
The Parkinson’s Action Network and RetireSafe, along with 58 other organizations sent a letter to Congress urging them to take action on the SBIR Reauthorization Act this Congressional session. The Parkinson’s Action Network recognizes the unique needs of small biotechnology companies and that shrinking the [...]
Filed under: Congress, Finding Cures, SBIR, patient groups | Tagged: Congress, Parkinson's Action Network, SBIR | Leave a Comment »
Posted on September 9, 2008 by cartier@bio
Welcome Back Senators! We hope you enjoyed your recess.
There is buzz that SBIR may make it on to the Senate calendar this session, but we do not have a definite date just yet. Stay tuned!
This act will increase access to early-stage funding for treatments and cures for debilitating diseases. With so many new treatments [...]
Filed under: Congress, Finding Cures, SBIR | Tagged: SBA, SBIR, Senate | Leave a Comment »
Posted on July 16, 2008 by cartier@bio
The feature story in the July 2008 Oncology Business Review is “On-Conversation with Michael Weingarten, Director, Small Business Innovation Research program (SBIR), Office of the Director, National Cancer Institute.”
NOTE: We have highlighted a few of Weingarten’s answers below. Please follow the links for the full interview.
OBR: HOW HAS THIS PROGRAM BEEN ADMINISTERED TO THIS [...]
Filed under: Finding Cures, SBIR, venture capital | Tagged: Cancer, Michael Weingarten, NIH, Phase I, SBIR, venture capital | Leave a Comment »
Posted on June 26, 2008 by cartier@bio
Hopes and Cures spokes to John Risner, President of The Children’s Tumor Foundation about the group’s work, in particular about funding for research. CTF is a non-profit 501(c) (3) medical foundation, dedicated to improving the health and well being of individuals and families affected by the neurofibromatosis (NF).
ABOUT NF
Neurofibromatosis (NF) is the term for [...]
Filed under: Finding Cures, SBIR, patient groups, venture capital | Tagged: CCF, children's tumor Foundation, Drug Discovery, NF, research, Tumors, VC | 2 Comments »
Posted on April 29, 2008 by cartier@bio
Alzheimer’s Drug Discovery Foundation
A new way to look at funding
The Alzheimer’s Drug Discovery Foundation (ADDF) raises money and awards grants to academic and biotechnology industry scientists who are conducting drug discovery research for Alzheimer’s Disease, related dementias and cognitive aging.
The way research is funded is evolving and by employing a venture capital model, [...]
Filed under: Finding Cures, SBIR, patient groups, venture capital | Tagged: Allon, Alzheimer's disease, Comentis, Estee Lauder, Fillit, SBIR | Leave a Comment »
Posted on April 21, 2008 by cartier@bio
We chatted with Virginia Ladd, President and Executive Director of the American Autoimmune Related Disease Association.
What is the scope of your work?
There are over 100 types of autoimmune related diseases, including lupus, type I diabetes, scleroderma, celiac, multiple sclerosis, Crohn’s disease, autoimmune hepatitis, rheumatoid arthritis, Graves’ disease, and Sjogren’s syndrome. The NIH estimates that 23.5 [...]
Filed under: Finding Cures, Non Profit, SBIR, patient groups | Tagged: Autoimmune Related Disease, celiac, crohn's disease, multiple sclerosis, Virginia Ladd | 2 Comments »
Posted on April 7, 2008 by cartier@bio
California Biotech Law Blog posted a summary of recent House hearings on reauthorizing the Small Business Innovation Research Program (SBIR).
In the world of biotechnology, the principle at stake is the United States’s claim to be an innovation engine in the global economy. Our members and their scientists are developing disease treatments and cures at a rapid rate, but because these cutting-edge treatments are so new, it takes 10-15 years before they reach the market. In the meantime, they thrive on traditional venture capital and the government’s version of VC: the SBIR program.
If Congress wants to perpetuate the image – and reality – of the US as the center of innovation, they must adapt the criteria for SBIR grants to match the reality for these budding treatments and burgeoning companies.
Filed under: BIO, Congress, Finding Cures, SBIR, venture capital | Tagged: biotech, MS, Parkinson's, SBIR | Leave a Comment »
Posted on April 2, 2008 by cartier@bio
What is State Science & Technology Institute (SSTI)?
It is a national nonprofit organization based outside of Columbus, OH, that is dedicated to leading, supporting, and strengthening public-private efforts to improve regional economies through science, technology and innovation. Part of SSTI’s mission is to serve as a neutral convener for discussion and advancement of key issues [...]
Filed under: Congress, Finding Cures, Non Profit | Tagged: House Small Business Committee, Innovation, Mark Skinner, Non Profit, research, SBIR, SSTI | Leave a Comment »
Posted on March 25, 2008 by cartier@bio
The Cystic Fibrosis Foundation is the leading organization in the United States devoted to curing and controlling cystic fibrosis. We spoke with Mary Dwight about her organization and the important work they do.
Can you tell us a bit about CFF’s purpose? The Cystic Fibrosis Foundation is the leader in developing drugs to treat and [...]
Filed under: Congress, Finding Cures, SBIR, patient groups | Tagged: Congress, cystic fibrosis, patient groups, SBIR | 3 Comments »